6 SMALL MOLECULE MARKET DYNAMICS 6 Overview 6 Key trends 8 Market drivers and restraints 12 References
14 CMO AND SPONSOR STRATEGIES 14 Preferred partner arrangements 17 Deal activity will focus on technologies and geographical markets 19 Emerging markets are increasingly important 20 References LIST OF FIGURES Figure 1: Comparison of the capabilities of the 10 leading small molecule CMOs
LIST OF TABLES Table 1: Major M&A deals in the CMO sector, 2010–12
Figure 1: Comparison of the capabilities of the 10 leading small molecule CMOs
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726